Overview

A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis

Status:
Not yet recruiting
Trial end date:
2026-05-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active Lupus Nephritis (LN).
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC